Ability Care Services

abilitycare.co.uk

Ability Care Services is a professional Organisation specialising in providing high quality Care at Home Assistants / Support Workers to care for a diverse range of Service Users within their home environment. Ability Care Services has been providing care at home services in the Renfrewshire area for 10 years.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industrial Impact

PALANTIR AND DEWPOINT THERAPEUTICS ANNOUNCE STRATEGIC PARTNERSHIP

Palantir Technologies Inc. | December 21, 2021

news image

Palantir Technologies Inc. a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics the leading biomolecular condensates company, announced a partnership for Palantir’s Foundry platform to help power Dewpoint’s efforts to discover treatments and cures for the most challenging diseases. Palantir Foundry will help to enable researchers at Dewpoint to further their understanding of condensates biology by analyzing lab data along with oth...

Read More

Industrial Impact

XTALPI AND CK LIFE SCIENCES TO COLLABORATE IN AI-EMPOWERED TUMOUR VACCINE RESEARCH AND DEVELOPMENT, OPENING A NEW PARADIGM FOR SCIENTIFIC INNOVATION

XtalPi Inc. | November 25, 2022

news image

XtalPi announced today that they are embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group. XtalPi and CK Life Sciences will leverage their respective expertise to jointly develop a novel AI tumour vaccine R&D platform to improve the discovery and design capabilities of tumour vaccines and accelerate the development of more vaccine types. The goal of this collaboration is to realize precision treatment for patients worldwide. Accordin...

Read More

MedTech

SOLVIAS ACQUIRES CERGENTIS TO BOLSTER BIOLOGICS AND CELL & GENE THERAPY CAPABILITIES

Solvias | July 18, 2022

news image

Solvias, one of the world's leading independent pharmaceutical testing and manufacturing companies, announced today that it has acquired Utrecht, Netherlands-based Cergentis. The acquisition bolsters Solvias' platform of biologics and cell and gene therapy testing solutions. According to pharmaceutical market intelligence provider, Evaluate, global sales of cell and gene therapies are projected to accelerate at a 63% compound annual growth rate through 2026. As more resear...

Read More

Industrial Impact

PRECIGEN ENTERS INTO AGREEMENT TO DIVEST NON-HEALTHCARE SUBSIDIARY TRANS OVA GENETICS

Precigen, Inc. | July 06, 2022

news image

Precigen, Inc. a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced that the Company has entered into a definitive agreement for the sale of its wholly-owned non-healthcare subsidiary, Trans Ova Genetics, L.C. an industry-leading animal reproductive technologies company, to URUS, a holding company with cooperative and private ownership, for $170 million in upfront cash and up to $10 million earn-out ba...

Read More
news image

Industrial Impact

PALANTIR AND DEWPOINT THERAPEUTICS ANNOUNCE STRATEGIC PARTNERSHIP

Palantir Technologies Inc. | December 21, 2021

Palantir Technologies Inc. a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics the leading biomolecular condensates company, announced a partnership for Palantir’s Foundry platform to help power Dewpoint’s efforts to discover treatments and cures for the most challenging diseases. Palantir Foundry will help to enable researchers at Dewpoint to further their understanding of condensates biology by analyzing lab data along with oth...

Read More
news image

Industrial Impact

XTALPI AND CK LIFE SCIENCES TO COLLABORATE IN AI-EMPOWERED TUMOUR VACCINE RESEARCH AND DEVELOPMENT, OPENING A NEW PARADIGM FOR SCIENTIFIC INNOVATION

XtalPi Inc. | November 25, 2022

XtalPi announced today that they are embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group. XtalPi and CK Life Sciences will leverage their respective expertise to jointly develop a novel AI tumour vaccine R&D platform to improve the discovery and design capabilities of tumour vaccines and accelerate the development of more vaccine types. The goal of this collaboration is to realize precision treatment for patients worldwide. Accordin...

Read More
news image

MedTech

SOLVIAS ACQUIRES CERGENTIS TO BOLSTER BIOLOGICS AND CELL & GENE THERAPY CAPABILITIES

Solvias | July 18, 2022

Solvias, one of the world's leading independent pharmaceutical testing and manufacturing companies, announced today that it has acquired Utrecht, Netherlands-based Cergentis. The acquisition bolsters Solvias' platform of biologics and cell and gene therapy testing solutions. According to pharmaceutical market intelligence provider, Evaluate, global sales of cell and gene therapies are projected to accelerate at a 63% compound annual growth rate through 2026. As more resear...

Read More
news image

Industrial Impact

PRECIGEN ENTERS INTO AGREEMENT TO DIVEST NON-HEALTHCARE SUBSIDIARY TRANS OVA GENETICS

Precigen, Inc. | July 06, 2022

Precigen, Inc. a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced that the Company has entered into a definitive agreement for the sale of its wholly-owned non-healthcare subsidiary, Trans Ova Genetics, L.C. an industry-leading animal reproductive technologies company, to URUS, a holding company with cooperative and private ownership, for $170 million in upfront cash and up to $10 million earn-out ba...

Read More